In the STEP UP trial of 1,407 adults with obesity, semaglutide 7.2 mg produced a mean weight change of 18.7% at week 72 versus 15.6% with semaglutide 2.4 mg, an estimated treatment difference of 3.1%
However, its super important to use them on the same day and time every week to reduce complications
While retatrutide is not FDA-approved yet, it is currently being developed by Eli Lilly with excellent early clinical results and is expected to be approved soon (predicted in 2027)
With professional administration, users often notice visible brightness and smoother tone within weeks
Drop one tablet in water twice daily before meals
Composed of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine coordinated with a divalent copper ion, GHK-Cu serves as a valuable research tool for examining copper-mediated biochemical processes and matrix-associated signaling mechanisms